Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

European Journal of Neuroscience

Volumn 12, Issue 6, 2000, Pages 2079-2086

  Drew, L J ^a   Harris, J ^a   Millns, P J ^a   Kendall, D A ^a   Chapman, V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Antinociception; Cannabinoid agonist HU210; Carrageenan inflammation

Indexed keywords

CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CARRAGEENAN; DEXANABINOL; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); RIMONABANT; SULFUR 35;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED RESPONSE; LUMBAR SPINAL CORD; NERVE CELL; NERVE CONDUCTION; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD DORSAL HORN;

ANIMALS; BINDING, COMPETITIVE; CANNABINOIDS; CARRAGEENAN; ELECTROPHYSIOLOGY; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); MYELITIS; NERVE FIBERS; NOCICEPTORS; PIPERIDINES; POSTERIOR HORN CELLS; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SULFUR RADIOISOTOPES; TETRAHYDROCANNABINOL;

EID: 0034119759     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00101.x     Document Type: Article

References (33)

1. 1 receptor to spinal nociceptive processing. 9th World Congress on Pain, International Association for the Study of Pain, Vienna, Austria, Abstract No 658.
2. Chapman, V. & Dickenson, A.H. (1997) Inflammation reveals inhibition of noxious responses of rat spinal neurones by carbamazepine. Neuroreport, 8, 1399-1404.
3. Chapman, V., Haley, J.E. & Dickenson, A.H. (1994) Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-D-aspartate receptor-mediated events. Anaesthesiology, 81, 1429-1435.
4. Diaz, A. & Dickenson, A.H. (1997) Blockade of spinal N- and P-type, but not L-type, calcium channels inhibits the excitability of rat dorsal horn neurons produced by subcutaneous formalin inflammation. Pain, 69, 93-100.
5. Dickenson, A.H. (1997) Mechanisms of central hypersensitivity: excitatory amino acid mechanisms and their control. In Dickenson, A.H. & Besson, J.M. (eds). The Pharmacology of Pain: Handbook of Experimental Pharmacology 130. Springer-Verlag, Heidelberg, pp. 167-196.
6. Di Marzo, V., Melck, D., Bisogno, T. & De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci., 21, 521-528.
7. Drew, L.J. & Chapman, V. (1999) Spinal administration of HU210, a cannabinoid agonist, attenuates nociceptive transmission in the carrageenin model of inflammation. British Pharmacological Society, 128, 14P.
8. Fields, H.L. & Meng, I.D. (1998) Watching the pot boil. Nature Med., 4, 1008-1009.
9. Hargreaves, K., Dubner, R., Brown, F., Flores, C. & Joris, J. (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 32, 77-88.
10. 35S]GTPγS binding in spinal cord slices of noninflamed and inflamed rats. British Pharmacological Society, 128, 290P.
11. Herkenham, M., Lynn, A.B., Johnson, M.S., Melvin, L.S., de Costa, B.R. & Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
12. Herzberg, U., Eliav, E., Bennett, G.J. & Kopin, I.J. (1997) The analgesic effects of R (+) -WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett., 221, 157-160.
13. Hohmann, A.G., Briley, E.M. & Herkenham, M. (1999a) Pre-and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord. Brain Res., 822, 17-25.
14. Hohmann, A.G. & Herkenham, M. (1998) Regulation of cannabinoid and mu opioid receptors in rat lumbar spinal cord following neonatal capsaicin treatment, Neurosci Lett., 252, 13-16.
15. Hohmann, A.G. & Herkenham, M. (1999) Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience, 90, 923-931.
16. Hohmann, A.G., Martin, W.J., Tsou, K. & Walker, J.M. (1995) Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci., 56, 2111-2118.
17. Hohmann, A.G., Tsou, K. & Walker, J.M. (1998) Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci Lett., 257, 119-122.
18. Hohmann, A.G., Tsou, K. & Walker, J.M. (1999b) Cannabinoid suppression of noxious heat-evoked activity in wide dynamic range neurons in the lumbar dorsal horn of the rat. J. Neurophysiol., 81, 575-583.
19. Lichtman, A.M. & Martin, B.R. (1991) Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther., 258, 517-523.
20. Manzanares, J., Corchero, J., Romero, J., Fernandez-Ruiz, J.J., Ramos, J.A. & Fuentes, J.A. (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci., 20, 287-294.
21. Martin, W.J., Loo, C.M. & Basbaum, A.I. (1999) Spinal cannabinoids are antiallodynic in rats with persistent inflammation. Pain, 82, 199-205.
22. Mason, D.J., Lowe, J. & Welch, S.P. (1999) Cannabinoid modulation of dynorphin A: correlation-induced antinociception. Eur. J. Pharmacol., 378, 237-248.
23. Mechoulam, R., Feigenbaum, J.J., Lander, N., Segal, M., Jarhe, T.U.C., Hiltunen, A.J. & Consroe, P. (1988) Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia, 44, 762-764.
24. Petitet, F., Jeantaud, B., Capet, M. & Doble, A. (1997) Interaction of brain cannabinoid receptors with guanine nucleotide binding protein. Biochem. Pharmacol., 54, 1267-1270.
25. Richardson, J.D., Aanonsen, L. & Hargreaves, K.M. (1998) Antihyperalgesic effects of spinal cannabinoids. Eur J. Pharmacol., 345, 145-153.
26. 35S]thio]-triphosphate binding. Proc. Natl Acad. Sci. USA, 92, 7242-7246.
27. 9-tetrahydrocannabinol-induced analgesia. Brain Res., 578, 8-12.
28. Stanfa, L.C., Sullivan, A.F. & Dickenson, A.H. (1992) Alterations in neuronal excitability and the potency of spinal mu, delta and kappa opioids after carrageenin-induced inflammation. Pain, 50, 345-354.
29. Strangman, N.M. & Walker, J.M. (1999) Cannabinoid WIN55, 212-2 inhibits the activity-dependent facilitation of spinal nociceptive responses. J. Neurophysiol., 81, 472-477.
30. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K. & Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
31. Twitchell, W., Brown, S. & Mackie, K. (1997) Cannabinoids inhibit N- and P/ Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol, 78, 43-50.
32. Weil-Fugazza, J., Godefroy, F. & LeBars, D. (1984) Increase in 5-HT synthesis in the dorsal part of the spinal cord, induced by a nociceptive stimulus: blockage by morphine. Brain Res., 297, 247-264.
33. Welch, S.P., Huffman, J.W. & Lowe, J. (1998) Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J. Pharmacol. Exp. Ther., 286, 1301-1308.